# Contact Sermorelin Rx: Editorial Inquiries

> Contact Sermorelin Rx for editorial inquiries and source corrections. We are an independent digest of the sermorelin research record — not a clinic, pharmacy, or vendor.

For editorial questions and source corrections on the sermorelin record.

## Editorial inquiries

Sermorelin Rx is an independent editorial digest of the sermorelin (GHRH(1-29)) research record. Use the form below for editorial questions, citation corrections, or to flag a source we should review. If you believe a study has been summarized inaccurately or a status claim needs updating, tell us which page and which claim, and point us to the source — we revise against the record.

We cannot answer medical questions, recommend doses, or provide treatment guidance, and we do not sell, source, or price any product. For anything clinical, consult a qualified healthcare professional. This page exists for editorial correspondence about the published literature, nothing more.

## What we can and cannot help with

We can help with: pointing you to the primary source behind a claim, correcting a citation, clarifying how a study was summarized, or explaining the dated regulatory record. We cannot help with: dosing, sourcing, purchasing, prescriptions, or personal medical advice — none of which this site provides. Messages asking for a source, a price, or a dose will not receive that kind of reply, because that is outside what an editorial digest does.

---

A status-and-access ledger of the sermorelin (GHRH 1-29) record — the former approval, the 2008 commercial withdrawal, the Category 1 503A standing and the WADA S2 line each logged to source and kept distinct; no clinic behind the console, no script filled here, nothing dispensed, sourced, or sold.